We found 5 drugmaker programs for Hemophilia A medicines and 4 charity funds (2 open at our last check). Tell us your insurance below and we'll show what to try first.
Help for Hemophilia A depends mostly on how you're covered. Pick the one that sounds like you. We'll name the funds and programs that fit, and what won't work, so you don't waste a phone call.
Independent foundations pay copays, coinsurance and sometimes insurance premiums for people who already have coverage. Funds open and close as donations come in, so each one shows what the foundation said on the date we checked.
Covers: Emergency living expenses ($250 prepaid card, once per year; referral through HTC or member organization; does not cover medical bills, copays or premiums). Up to $250 a year.
Covers: Out-of-pocket costs for approved medications. Up to $12,500 a year.
Covers: Copays, coinsurance, deductibles and other health-related expenses.
Covers: Copays for FDA-approved medications (plus travel for some funds).
Copay cards lower what people with private insurance pay. Federal rules bar them for Medicare, Medicaid and TRICARE. Free medicine programs are for people without enough coverage and usually have income limits. We read each program on the drugmaker's own site.
Commercially insured patients may pay as little as $0 per fill for Alhemo, up to $15,000 savings per calendar year; offer valid 48 months from enrollment.
JumpStart and Interim programs may provide a limited free supply if commercial insurance is delayed or has a gap.
Patients with no insurance may qualify for free medicine through the Novo Nordisk Patient Assistance Program.
Patient Trial Program may provide a free, limited supply for patients new to treatment; provider completes the NovoCare enrollment form.
NovoCare checks insurance coverage, shares prior authorization information, explains appeals, and coordinates with a specialty pharmacy.
Savings offer excludes Medicare, Medicaid, Medigap, VA, DOD, TRICARE and other government programs. NovoCare notes services may vary by product; call 1-844-668-6732 to confirm eligibility.
HemAssist Copay Assistance Program: eligible commercially insured patients may get Altuviiio for as little as $0. Not valid with Medicare, Medicaid, Medigap, VA, DoD, TRICARE or state programs.
Free Trial Program: patients prescribed Altuviiio for the first time can get their first 30-day supply, generally within 24 to 48 hours of a valid prescription. One use per patient per product; not valid in Vermont.
Patient Assistance Program may help eligible Altuviiio patients who are uninsured, underinsured, or temporarily lose insurance coverage.
Case Managers run insurance investigations and help coordinate shipments; Clinical Educators give supplemental infusion training and dosing help.
HemAssist calls within 24 hours of enrollment. Mon-Fri 8 AM-7 PM ET.
HEMLIBRA Co-pay Assistance Program: eligible commercially insured patients could pay as little as $0 per treatment, up to $15,000 per calendar year. Excludes Medicare, Medicaid, TRICARE.
Genentech Patient Foundation gives free HEMLIBRA to eligible uninsured patients or insured patients without coverage, with incomes under $150,000; other income-based criteria apply.
Referrals to independent co-pay assistance foundations, which may help commercially or publicly insured patients.
Free drug comes from the separate Genentech Patient Foundation (888-941-3331); both a patient consent form and a prescriber form are required. Local Account and Community Managers (Genentech employees) also offer support.
HYMPAVZI Co-pay Savings Program: eligible commercially insured patients may pay as little as $0, up to $15,000 per calendar year.
Interim Care Rx: during insurance delays or denials, eligible commercially insured patients may get up to 12 months free (6 months in Minnesota and Rhode Island).
Pfizer Patient Assistance Program may provide free medicine to eligible uninsured or government-insured underinsured patients; income and household size apply.
Voucher Program: eligible patients new to HYMPAVZI may receive a free one-time 4-week supply, including the loading dose.
Patient Case Managers explain insurance coverage and identify financial help; Patient Navigators connect patients to community support.
Co-pay card excludes Medicare, Medicaid, TRICARE, VA and other government programs. Free medicine comes through the Pfizer Patient Assistance Foundation, a separate entity (see Pfizer RxPathways).
HemAssist Copay Assistance Program: eligible patients may get Qfitlia for as little as $0. Not valid with Medicare, Medicaid, VA, DoD or TRICARE.
QuickStart: patients prescribed Qfitlia for the first time can get up to 6 months of product while insurance coverage is pending.
Patient Assistance Program may help eligible patients who are uninsured, underinsured or temporarily lose insurance coverage.
Case Managers run insurance investigations; Clinical Educators help with injection training, antithrombin testing and dose adjustments.
HemAssist calls within 24 hours of enrollment. Mon-Fri 8 AM-7 PM ET. Sanofi also has a Labcorp partnership for label-required antithrombin and liver tests.
Most of these programs start with one call, and having these ready makes it shorter. Tick them off as you go. Nothing here is saved or sent anywhere.
Call the drugmaker's support line first. Its case managers check your benefits and often fill out forms with your doctor. If a charity fund is closed, sign up on the foundation's page to hear when it reopens. Most programs need renewing every year, and many copay cards reset in January.
Yes. Trial Friend lists 5 drugmaker programs for Hemophilia A medicines and 4 charity funds, 2 of them open at our last check. We checked every one at the source on or before October 19, 2026. Which ones fit depends on your insurance. Copay cards are for people with private insurance, charity funds usually need some insurance, and free medicine programs are for people without enough coverage.
No. Federal rules bar drugmaker copay cards for drugs paid by Medicare, Medicaid or TRICARE. For Hemophilia A, 1 charity fund on this page accepts Medicare (1 open at our last check), and 1 drugmaker free medicine program names Medicare patients among those who may qualify. In 2026, Medicare Part D also caps yearly out-of-pocket costs for covered drugs at $2,100.
At our last check, Hemophilia Federation of America's Helping Hands Program fund, TotalAssist's Hemophilia fund were open to new applicants. Funds open and close as donations come in, so check the foundation's page before you apply.
Of the drugmaker programs for Hemophilia A medicines, 5 offer free medicine to people without insurance who qualify, usually with income limits. Most charity funds pay copays and premiums, so they need some insurance. The drugmaker's support line can also check whether you qualify for coverage you don't have yet.
How we check: drugmaker programs come only from each drugmaker's own pages. Fund status is copied from each foundation's list (Hemophilia Federation of America, TotalAssist, The Assistance Fund, Good Days) on the date shown. Programs change, so confirm with the program before you rely on it. Trial Friend shares information, not financial, legal or medical advice, and each program decides who qualifies. See something wrong? Email jason@trialfriend.com.
